Dry Eye Disease Market Size, Share, Growth Analysis, By Product(Artificial Tears, Anti-inflammatory Drugs, Punctal Plugs, Secretagogues), By Distribution Channel(Hospital Pharmacies, Independent Pharmacies & Drug Stores, Online Pharmacies), By Region - Industry Forecast 2024-2031

Dry Eye Disease Market size was valued at USD 5.13 billion in 2019 and is poised to grow from USD 5.53 billion in 2023 to USD 10.92 billion by 2031, growing at a CAGR of 7.85% in the forecast period (2024-2031).

Dry eye is an ocular surface disease that causes the eye to produce insufficient tears and is associated with symptoms of ocular discomfort. Keratitis sicca, keratoconjunctivitis sicca (KCS), xerophthalmia, dry eye syndrome (DES), and dysfunctional tear syndrome are all names for dry eye disease (DTS). Clinical trials and research and development activities are expected to gain traction in order to increase the penetration of dry eye treatments and medications.

Dry eye disease affects a significant proportion of the global population (from middle to old age). Women are more likely than men to contract the disease. According to the World Health Organization Facts of 2021, the proportion of the global population aged 60 and up will nearly double between 2015 and 2050, rising from 12% to 22%. By 2050, low- and middle-income countries will house 80% of the world's elderly. The elderly population is expected to grow, and this group is more vulnerable to eye-related disorders such as dry eye. This factor could influence the market in the future.

US Dry Eye Disease Market  is poised to grow at a sustainable CAGR for the next forecast year.